Adenylate Kinase 2 Promotes Tumor Progression in Small-cell Lung Cancer <i>via</i> PI3K/AKT/mTOR Signaling

AK2 acts as an oncogenic driver in SCLC, promoting tumor progression through PI3K/AKT/mTOR signaling. Targeting AK2 may represent a novel therapeutic strategy and predictive biomarker in SCLC management.

Authors

Yong Sub Na (ORCID: https://orcid.org/0000-0003-2506-2673)
Hong-Beum Kim (ORCID: https://orcid.org/0000-0001-9434-0708)
Sang-Gon Park
HEE-JEONG LEE
SEONG-HUN KIM

Institutions

Chosun University (KR)
Chosun University Hospital (KR)

Publication Details

Journal: Anticancer Research
Published: 2025-12-30
DOI: https://doi.org/10.21873/anticanres.17935
Primary Topic: Lung Cancer Research Studies
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Adenylate Kinase 2 Promotes Tumor Progression in Small-cell Lung Cancer via PI3K/AKT/mTOR Signaling

Yong Sub Na, Hong-Beum Kim, Sang-Gon Park, HEE-JEONG LEE et al.

Dec 30, 2025

Anticancer Research

Lung Cancer Research Studies

article

Adenylate Kinase 2 Promotes Tumor Progression in Small-cell Lung Cancer via PI3K/AKT/mTOR Signaling

Yong Sub Na, Hong-Beum Kim, Sang-Gon Park, HEE-JEONG LEE, SEONG-HUN KIM

December 30, 2025article en

Abstract

Anticancer ResearchVol. 46(1)

Chosun University (KR), Chosun University Hospital (KR)

Good health and well-being

Openalex Percentile: Top 30%

Lung Cancer Research Studies

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Adenylate Kinase 2 Promotes Tumor Progression in Small-cell Lung Cancer <i>via</i> PI3K/AKT/mTOR Signaling — Yong Sub Na, Hong-Beum Kim, et al. · Anticancer Research (2025) | TGRS Research Map | TGRS